KEGG: vg:935180
The PEDV E protein is the smallest structural protein of the virus with high expression levels. It plays a crucial role in viral assembly through interaction with the M protein . Structurally, the E protein's tertiary configuration has been modeled using Alphafold2, with the highest accuracy model selected according to the predicted local distance difference test (pLDDT) .
The E protein is encoded in the PEDV genome (approximately 28 kb) which contains at least six open reading frames (ORFs): ORF1a, ORF1b, spike (S), envelope (E), membrane (M), and nucleocapsid (N) . In viruses lacking the E protein, viral titer is significantly decreased, highlighting its essential role in viral replication and assembly .
Recombinant PEDV E protein can be effectively generated through expression systems similar to those used for other PEDV structural proteins. Based on established protocols for PEDV structural proteins, the following methodology is recommended:
Gene synthesis or amplification of the E gene sequence from PEDV isolates
Cloning into an appropriate expression vector (such as those with TEV protease cleavage sites for tag removal)
Transfection into mammalian expression systems such as HEK293 cells using polyethylenimine (PEI) at an optimal 1:4 (wt/wt) plasmid/PEI ratio
Expression in serum-free medium (such as FreeStyle 293 expression medium) at 37°C with 5% CO₂ under orbital shaking conditions (120 rpm)
Harvesting culture supernatants by centrifugation and filter sterilization
Purification using appropriate affinity chromatography methods
Host protein interactions with PEDV E protein can be identified and validated through multiple complementary approaches:
Identification Methods:
Co-immunoprecipitation with PEDV E protein-labeled antibodies coupled with tandem liquid-chromatography mass-spectroscopy (LC-MS/MS)
Bioinformatical analysis to identify associated pathways in eukaryotes (such as ribosome biogenesis, RNA transport, and amino acid biosynthesis)
Validation Methods:
Co-immunoprecipitation assays to confirm specific protein interactions
Confocal microscopy analysis to visualize co-localization
Overexpression or knockdown studies to assess functional relevance of interactions
Research has successfully validated interactions between PEDV E protein and several host proteins including isocitrate dehydrogenase [NAD] β-subunit (NAD-IDH-β), DNA-directed RNA polymerase II subunit RPB9, and mRNA-associated protein MRNP 41 .
Advanced computational modeling can predict interaction sites between PEDV E protein and host proteins through the following methodology:
Tertiary structure prediction: Use Alphafold2 to generate the E protein model with highest accuracy as determined by predicted local distance difference test (pLDDT)
Interaction modeling: Employ HADDOCK 2.4 to detect potential interacting subunits and predict interaction models with host proteins
Optimal model selection: Screen interaction models based on docking parameters including:
Interaction site prediction: Use Proteins, Interfaces, Structures, and Assemblies (PDBePISA) to predict:
Visualization and refinement: Demonstrate three-dimensional structure using PyMOL, selecting polar bonds within 5Å of the viral protein and host protein for amino acid interactions
Research has identified specific interaction sites including PEDV_E-IDHβ: ALA-48 vs. LYS-357, PEDV_E-MRNP 41: TYR-50 vs. LEU-169, and PEDV_E-RBP9: ARG-55 vs. GLN-74 .
The PEDV E protein contributes to viral pathogenesis through multiple mechanisms:
Stress granule formation: PEDV E protein induces stress granules and attenuates protein translation through activation of the PERK/eIF2α pathway , which can be studied through:
Fluorescent microscopy to visualize stress granule formation
Western blotting to assess phosphorylation of eIF2α
Polysome profiling to measure translation efficiency
Interaction with host metabolism: E protein may regulate host metabolism by interacting with proteins like NAD-IDH-β, potentially reducing available energy for viral replication . Methods to study this include:
Overexpression experiments (NAD-IDH-β overexpression has been shown to significantly inhibit viral replication)
Metabolic profiling to measure changes in key metabolites
Viral titer assays to quantify replication efficiency
Viral assembly: E protein's interaction with M protein is crucial for viral assembly . This can be studied through:
Electron microscopy to visualize virion formation
Co-immunoprecipitation to confirm protein-protein interactions
Mutagenesis studies to identify critical interaction domains
The E protein region is involved in recombination events that contribute to PEDV evolution. Research methodologies to study this include:
Genome sequencing of multiple PEDV isolates to identify potential recombination events
Phylogenetic analysis to classify PEDV strains into distinct genogroups, which has revealed that all PEDV strains can be classified into two distinct genogroups (G1 and G2)
Recombination detection using specialized software such as Recombination Detection Program v4 (RDP4) with support from multiple analytical programs (≥6 programs)
Breakpoint identification through bootstrap analysis, which has detected major recombination breakpoints in the viral genome
Structural protein gene analysis in the order of 5′-S-ORF3-E-M-N-3′ to identify recombination patterns
Research has identified recombination events in regions spanning partial S, ORF3, E, M, and partial N genes, highlighting the importance of monitoring E protein sequences in the context of viral evolution .
Development of antibody-based assays for PEDV E protein follows these methodological steps:
Generation of recombinant E (rE) protein using appropriate expression systems
Coupling of purified rE protein to carboxylated magnetic microspheres (such as MagPlex-C Microspheres)
Buffer optimization to exclude matrix inhibitory effects and select optimal buffer combinations
Assay validation through:
Protocol development for a fluorescent microbead-based immunoassay (FMIA) including:
Data analysis using median fluorescent intensity (MFI) expressed as sample/positive (S/P) ratio
This approach enables specific detection of antibodies against PEDV E protein, supporting both research and diagnostic applications.
When studying PEDV E protein interactions with cellular compartments, researchers should consider:
Cell line selection:
Viral strain considerations:
Detection methods:
Controls and validation:
Include multiple viral strains with different pathogenicity profiles
Use both overexpression and knockdown/knockout approaches to confirm functional relationships
Employ multiple complementary techniques to validate interactions
The experimental design should account for strain-specific differences in replication kinetics, with some strains reaching peak virus titers at 24 hours post-infection while others peak later at 36 hours post-infection .